Search Results - "Cabeceiras, Peter"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Engineered CRISPR prime editors with compact, untethered reverse transcriptases by Grünewald, Julian, Miller, Bret R., Szalay, Regan N., Cabeceiras, Peter K., Woodilla, Christopher J., Holtz, Eliza Jane B., Petri, Karl, Joung, J. Keith

    Published in Nature biotechnology (01-03-2023)
    “…The CRISPR prime editor PE2 consists of a Streptococcus pyogenes Cas9 nickase (nSpCas9) fused at its C-terminus to a Moloney murine leukemia virus reverse…”
    Get full text
    Journal Article
  2. 2

    The RAC1 P29S Hotspot Mutation in Melanoma Confers Resistance to Pharmacological Inhibition of RAF by WATSON, Ian R, LIREN LI, TSAI, Kenneth Y, DAVIES, Michael A, MILLS, Gordon B, CHIN, Lynda, CABECEIRAS, Peter K, MAHDAVI, Mozhdeh, GUTSCHNER, Tony, GENOVESE, Giannicola, GUOCAN WANG, ZHUANGNA FANG, TEPPER, James M, STEMKE-HALE, Katherine

    Published in Cancer research (Chicago, Ill.) (01-09-2014)
    “…Following mutations in BRAF and NRAS, the RAC1 c.85C>T single-nucleotide variant (SNV) encoding P29S amino acid change represents the next most frequently…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Abstract 659: Novel refinements for the autochthonous mouse model of cancer by Cabeceiras, Peter K., Joshi, Nikhil S., Jacks, Tyler

    Published in Cancer research (Chicago, Ill.) (15-07-2016)
    “…There are many levels of genetic regulation at play in autochthonous mouse models of cancer. For instance, mouse models can be programed to knockout tumor…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Novel Extracellular Vesicle Modalities for Delivery of Genome Editor Ribonucleoprotein Complexes by Cabeceiras, Peter Keith

    Published 01-01-2022
    “…Genome editing reagents have undergone rapid advancements in terms of specificity and the types of edits that can be executed, but the hurdle of delivery in…”
    Get full text
    Dissertation
  7. 7
  8. 8

    Abstract LB-214: The RAC1 P29S hotspot mutation in melanoma confers resistance to pharmacological inhibition of RAF by Watson, Ian R., Li, Liren, Cabeceiras, Peter K., Mahdavi, Mozhdeh, Fang, Zhuangna, Stemke-Hale, Katherine, Mills, Gordon B., Chin, Lynda

    Published in Cancer research (Chicago, Ill.) (01-10-2014)
    “…Following recurrent mutations in BRAF and NRAS, the RAC1 c.85C > T single nucleotide variant encoding P29S amino acid change represents the next most…”
    Get full text
    Journal Article